ARTICLE | Clinical News
Kinrix regulatory update
July 30, 2007 7:00 AM UTC
GSK submitted a marketing application to FDA for Kinrix, a DTaP-IPV vaccine, to vaccinate against diptheria, tetanus, acellular pertusis and polio in children 4 to 6 years of age. ...